Nanochon

Nanochon is a biotechnology startup based in the United States, founded in 2016. The company is focused on developing innovative solutions for cartilage loss and damage, aiming to revolutionize the treatment of joint diseases. Its slogan, "Nanochon is developing highly effective, minimally invasive and low cost solutions for cartilage loss and damage," encapsulates its mission. Currently, the standard treatment for joint disease is total joint replacement, which is invasive and not permanent, limiting its use to patients aged 55 or older. Nanochon addresses this gap by developing an implant that not only replaces lost and damaged cartilage but also stimulates new tissue growth. Utilizing 3-D printing and a novel material, the Nanochon implant serves as both an orthopedic load-bearing implant and a tissue growth scaffold, offering the potential for faster and more successful recoveries for patients. Cultivate(MD) made a Venture Round investment in Nanochon on 27 November 2023. This investment signifies external validation of Nanochon's innovative approach and its potential to significantly impact the orthopedic and biotechnology industries. Nanochon's efforts not only aim to improve patient outcomes but also to reduce costs for health providers, payers, and patients, setting a new clinical standard for cartilage restoration.